Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
AMAG Pharmaceuticals, Inc. (NQ: AMAG)
22.40 USD  -2.68 (-10.69%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 22, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about AMAG Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Market Wrap for Wednesday, May 22: Stocks Pullback As Bernanke Says Bond Buying Could Slow
May 22, 2013
In Congressional testimony on Wednesday, Federal Reserve Chairman Ben Bernanke said that the central bank could begin winding down its $85 billion-per-month bond-buying program at one of its "next few... Read More
category Earnings , BAH , Benzinga , and 29 more.
from Latest Articles from Benzinga.com
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc.
May 22, 2013
from PR Newswire
AMAG Pharma (AMAG) Declines After Recalling Batch of Rienso
May 22, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8362197 for the full story. Read More
from StreetInsider.com News Articles
CORRECTED-Amag investigates anemia drug after report of death in Switzerland
May 21, 2013
(Corrects headline to "investigates." Amag did not say the drug caused the fatality.) Read More
category companyNews
from Reuters: Company News
Ferumoxytol Treatment Produced Significant Hemoglobin Increases in Adult Iron Deficiency Anemia Patients With Gastrointestinal Disease Who Had Failed or Could Not Tolerate Oral Iron Therapy
May 21, 2013
Sub-Group Analysis of a Phase III Trial Being Presented Today in a Poster Session at Digestive Disease Week Read More
from GlobeNewswire News Releases
AMAG July Options Begin Trading
May 20, 2013
Investors in AMAG Pharmaceuticals, Inc. (AMAG) saw new options become available today, for the July expiration. Read More
category Stocks
from Market News Video
Watch for Continued Gains in Shares of AMAG Pharmaceuticals (AMAG)
May 15, 2013
from Comtex SmarTrend® News Briefs
Recent 52-Week High Exceeded in Shares of AMAG Pharmaceuticals (AMAG)
May 13, 2013
from Comtex SmarTrend® News Briefs
Ferumoxytol Results in Significant Hemoglobin Increases in Adult Iron Deficiency Anemia Patients With Abnormal Uterine Bleeding Who Had Failed or Could Not Tolerate Oral Iron Therapy
May 06, 2013
Sub-Group Analysis of a Phase III, Randomized, Placebo-Controlled Trial Being Presented Today in a Poster Session at the American College of Obstetrics and Gynecology Annual Meeting Read More
from GlobeNewswire News Releases
AMAG Pharmaceuticals to Present at the Needham Healthcare Conference
April 26, 2013
from Business Wire News Releases
AMAG Announces First Quarter 2013 Financial Results
April 23, 2013
from Business Wire News Releases
AMAG Pharmaceuticals, Inc. to Host Conference Call on April 23, 2013 at 4:30 p.m. ET to Discuss Financial Results for the Quarter Ended March 31, 2013
April 19, 2013
from Business Wire News Releases
41.6% Return Seen to Date on SmarTrend AMAG Pharmaceuticals Call (AMAG)
April 11, 2013
from Comtex SmarTrend® News Briefs
Uptrend Call Working As AMAG Pharmaceuticals Stock Rises 45.4% (AMAG)
April 04, 2013
from Comtex SmarTrend® News Briefs
AMAG Pharmaceuticals Up 37.6% Since SmarTrend Uptrend Call (AMAG)
March 20, 2013
from Comtex SmarTrend® News Briefs
Recent 52-Week High Exceeded in Shares of AMAG Pharmaceuticals (AMAG)
March 18, 2013
from Comtex SmarTrend® News Briefs
Leerink Swann Raises PT on AMAG Pharmaceuticals
March 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8188598 for the full story. Read More
from StreetInsider.com News Articles
AMAG Pharma (AMAG) Medical Chief Allen to Leave
March 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8187475 for the full story. Read More
from StreetInsider.com News Articles
AMAG Announces Positive Preliminary from IDA-303 study
March 15, 2013
AMAG Pharmaceuticals (NASDAQ: AMAG ) today announced positive preliminary data from the IDA-303 study. IDA-303 is a single arm, open-label extension study that evaluated the safety and efficacy of Read More
category Contracts , AMAG , Management , and 3 more.
from Latest Articles from Benzinga.com
AMAG Pharma (AMAG) Reports Statistically Significant Data from IDA-303
March 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8187449 for the full story. Read More
from StreetInsider.com News Articles
AMAG Pharmaceuticals Announces Positive Preliminary Results from an Extension Study Evaluating the Safety and Efficacy of Repeat Dosing with Ferumoxytol in Patients with Persistent or Recurring Iron D
March 15, 2013
from Business Wire News Releases
AMAG Pharmaceuticals Shares Up 18.9% Since SmarTrend's Buy Recommendation (AMAG)
March 13, 2013
from Comtex SmarTrend® News Briefs
AMAG Pharma (AMAG) sNDA for Feraheme Accepted by U.S. FDA
March 06, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8160939 for the full story. Read More
from StreetInsider.com News Articles
AMAG Pharmaceuticals Announces FDA Acceptance of Supplemental New Drug Application for Feraheme Label Expansion to Include Iron Deficiency Anemia Patients Who Cannot Take Oral Iron
March 06, 2013
from Business Wire News Releases
Upgrade Alert for AMAG Pharmaceuticals (AMAG)
March 04, 2013
from Comtex SmarTrend® News Briefs
JPMorgan Upgrades AMAG Pharmaceuticals (AMAG) to Neutral
March 04, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8150213 for the full story. Read More
from StreetInsider.com News Articles
Top Analyst Upgrades and Downgrades (AMAG, AON, BMY, SCHW, COH, BVN, DF, GPS, HGG, LXK, MRK, KORS, NS, RRGB, TIF, TJX, YHOO)
March 04, 2013
DailyFinance.com : These are some of this Monday's top analyst upgrades, downgrades and initiations seen from Wall St. research calls. AMAG Pharmaceuticals Inc. (NASDAQ: AMAG) raised to Neutral at J.P.... Read More
category bmy , coh , yhoo , and 14 more.
from DailyFinance.com
AMAG Pharmaceuticals, Inc. (AMAG) Misses Q4 EPS by 10c; Reaffirms FY13 Rev Outlook
March 01, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8146109 for the full story. Read More
from StreetInsider.com News Articles
AMAG Announces Fourth Quarter and Year End 2012 Financial Results
March 01, 2013
from Business Wire News Releases
AMAG Pharmaceuticals, Inc. to Present at Upcoming Healthcare Conferences
February 21, 2013
from Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here